Artificial Intelligence (Al) in Healthcare Market – Global Forecast to 2030
헬스케어 시장의 인공지능(AI) – 제공내용(통합), 기능(진단, 게놈, 정밀의료, 방사선, 면역요법, 약국, 공급망), 용도(임상), 최종 사용자(병원), 지역별 – 2030년까지의 세계 예측
Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region- Global Forecast to 2030
조사회사 | MarketsandMarkets |
출판년월 | 2024년12월 |
페이지 수 | 738 |
도표 수 | 943 |
라이센스 | Single User License |
가격 | USD 4,950 |
구성 | 영문조사보고서 |
Report Overview
The global Artificial Intelligence (AI) in healthcare market is projected to reach USD 164.16 billion by 2030 from USD 14.92 billion in 2024, at a CAGR of 49.1% during the forecast period.
헬스케어 시장의 세계 인공지능(AI) 시장은 2024년 149억 2000만 달러에서 2030년까지 1,641억 6000만 달러에 이를 것으로 예측되며, 예측 기간 중 CAGR은 49.1%입니다.
The market is expected to grow as a result of the increasing investments & funding by public-private organizations, the rapid proliferation of AI in the healthcare industry, and the increasing focus on developing human-aware AI systems. Moreover, the market has experienced growth due to rising demand for enhanced services due to a disproportionate ratio between the healthcare workforce and patient numbers. However, insufficient IT infrastructure, and reluctance towards adoption of AI-based healthcare solutions in emerging economies are some of the factors that are expected to pose a challenge to the market growth.

“Cloud-based segment is expected to register highest growth during the forecast period, by deployment.”
The Artificial Intelligence (AI) in healthcare software segment is segmented into on-premise, cloud-based, and hybrid model. In 2023, the cloud-based segment is expected to register the highest growth during the forecast period. The growth of the cloud segment is attributed to the ample number of advantages offered by this model, such as the seamless integration of data from various silos, unlimited user access from remote locations, low maintenance costs, high security, privacy, easy accessibility, no upfront capital investment for hardware, and extreme capacity flexibility and optimized resource utilization. Moreover, the increasing demand for remote healthcare services and telemedicine solutions has accelerated the adoption of cloud technologies that facilitate easy access to imaging tools and data sharing among healthcare professionals, further contributing to the segment’s growth.
“Hospitals & Clinics dominated the market in the Artificial Intelligence (AI) in healthcare market for healthcare providers, by end user in 2023.”’
The hospitals & clinics, ambulatory surgical centers, home healthcare agencies & assisted living facilities, diagnostic & imaging centers, pharmacies, and other healthcare providers make up the healthcare providers segment of the end user of the Artificial Intelligence (AI) in healthcare market. In 2023, the hospitals & clinics accounted for a significant share of the Artificial Intelligence (AI) in healthcare market, by end user. The prominent position of this segment is due to the push for personalized medicine, demand for precise diagnostics & surgical planning, rise in minimally-invasive procedures, and the need for interoperability with existing systems. AI applications, such as clinical decision support systems, predictive analytics for patient outcomes, and automated administrative workflows, address critical challenges like workforce shortages and rising patient loads. Additionally, advancements in medical imaging, integration with EHR systems, and government support for AI-driven healthcare transformation further encourage adoption.
“Asia Pacific is expected to register highest market growth during the forecast period.”
The Artificial Intelligence (AI) in healthcare market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register the highest growth during the forecast period. The high growth of this region is attributed to the presence of a large and growing patient population in the region, the increasing need for innovative therapies, the emergence of big data in healthcare, increasing spending on HCIT infrastructure, and the shifting focus of various market players on emerging countries in the region. Government initiatives to promote the adoption of digital & technologically enabled solutions across the healthcare industry and a significant focus on integrating sophisticated technologies across the workflows also contribute to the growth.

The break-down of primary participants is as mentioned below:
- By Company Type – Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
- By Designation – Directors: 30%, Manager: 34%, and Others: 36%
- By Region – North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%
List of Companies Profiled in the Report
- Koninklijke Philips N.V. (Netherlands)
- Microsoft (US)
- Siemens Healthineers AG (Germany)
- NVIDIA Corporation (US)
- Epic Systems Corporation (US)
- GE Healthcare (US)
- Medtronic (US)
- Oracle (US)
- Change Healthcare (US)
- Veradigm LLC (US)
- Merative (IBM) (US)
- Google (US)
- Cognizant (US)
- Johnsons & Johnsons (US)
- Amazon Web Services, Inc. (US)
- SOPHiA GENETICS (US)
- Riverian Technologies (US)
- Terarecon (ConcertAI) (US)
- 3M (US)
- Tempus (US)
- Viz.ai (US)
- Recursion (US)
- Qure.ai (India)
- Atomwise Inc. (US)
- Entilic (US)
- Personify Health (US)

Research Coverage:
The report analyzes the Artificial Intelligence (AI) in healthcare market and aims to estimate the market size and future growth potential of various market segments, based on offering, solution type, imaging modality, applicarion, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total Artificial Intelligence (AI) in healthcare market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
- Analysis of key drivers (exponential growth in data volume and complexity due to surging adoption of digital technologies, significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases, rapid proliferation of AI in healthcare sector, growing need for improvised healthcare services), restraints (reluctance among medical practitioners to adopt AI-based technologies, shortage of skilled AI professionals handling AI-powered solutions, lack of standardized frameworks for AL and ML technologies), opportunities (increasing use of AI-powered solutions in elderly care, increasing focus on developing human-aware AI systems, rising use of technology in pharmaceuticals industry, strategic partnerships and collaborations among healthcare companies and AI technology providers), challenges (inaccurate predictions due to scarcity of high-quality healthcare data, concerns regarding data privacy, lack of interoperability between AI solutions offered by different vendors) are factors contributing the growth of the Artificial Intelligence (AI) in healthcare market.
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the Artificial Intelligence (AI) in healthcare market.
- Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region.
- Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the Artificial Intelligence (AI) in healthcare market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Artificial Intelligence (AI) in healthcare market such as Koninklijke Philips N.V. (Netherlands), Microsoft (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US).
Table of Contents
1 INTRODUCTION 57
1.1 STUDY OBJECTIVES 57
1.2 MARKET DEFINITION 57
1.3 STUDY SCOPE 58
1.3.1 MARKETS COVERED & REGIONAL SCOPE 58
1.3.2 INCLUSIONS & EXCLUSIONS 59
1.3.3 YEARS CONSIDERED 62
1.4 CURRENCY CONSIDERED 63
1.5 STAKEHOLDERS 63
1.6 SUMMARY OF CHANGES 64
2 RESEARCH METHODOLOGY 65
2.1 RESEARCH DATA 65
2.1.1 SECONDARY DATA 66
2.1.1.1 Key data from secondary sources 67
2.1.2 PRIMARY DATA 67
2.1.2.1 Key industry insights 69
2.2 MARKET SIZE ESTIMATION 70
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 75
2.4 MARKET SHARE ESTIMATION 77
2.5 STUDY ASSUMPTIONS 77
2.6 LIMITATIONS 77
2.6.1 METHODOLOGY-RELATED LIMITATIONS 77
2.6.2 SCOPE-RELATED LIMITATIONS 77
2.7 RISK ASSESSMENT 78
3 EXECUTIVE SUMMARY 79
4 PREMIUM INSIGHTS 85
4.1 AI IN HEALTHCARE MARKET OVERVIEW 85
4.2 ASIA PACIFIC: AI IN HEALTHCARE, BY OFFERING AND COUNTRY (2024) 86
4.3 AI IN HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 87
4.4 AI IN HEALTHCARE MARKET: REGIONAL MIX (2022−2030) 87
4.5 AI IN HEALTHCARE: DEVELOPED VS. EMERGING MARKETS 88
5 MARKET OVERVIEW 89
5.1 INTRODUCTION 89
5.2 MARKET DYNAMICS 89
5.2.1 DRIVERS 91
5.2.1.1 Growing need for early detection and diagnosis 91
5.2.1.2 Exponential growth in data volume and complexity due to surging adoption of digital technologies 91
5.2.1.3 Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases 92
5.2.1.4 Rapid proliferation of AI in healthcare sector 92
5.2.1.5 Growing need for improvised healthcare services 93
5.2.2 RESTRAINTS 93
5.2.2.1 Reluctance among medical practitioners to adopt AI-based technologies 93
5.2.2.2 Shortage of skilled AI professionals handling AI-powered solutions 94
5.2.2.3 Lack of standardized frameworks for AL and ML technologies 95
5.2.3 OPPORTUNITIES 95
5.2.3.1 Increasing use of AI-powered solutions in elderly care 95
5.2.3.2 Increasing focus on developing human-aware AI systems 95
5.2.3.3 Strategic partnerships and collaborations among healthcare companies and AI technology providers 96
5.2.4 CHALLENGES 98
5.2.4.1 Inaccurate predictions due to scarcity of high-quality healthcare data 98
5.2.4.2 Concerns regarding data privacy 98
5.2.4.3 Lack of interoperability between AI solutions offered by different vendors 100
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 101
5.4 TECHNOLOGY ANALYSIS 101
5.4.1 KEY TECHNOLOGIES 101
5.4.1.1 Machine learning (ML) & deep learning 101
5.4.1.2 Natural language processing (NLP) 102
5.4.1.3 Computer vision (CV) 102
5.4.2 COMPLEMENTARY TECHNOLOGIES 102
5.4.2.1 Cloud computing 102
5.4.2.2 Digital twins 103
5.4.2.3 Robotic process automation (RPA) 103
5.4.3 ADJACENT TECHNOLOGIES 103
5.4.3.1 Blockchain 103
5.4.3.2 Augmented and virtual reality (AR/VR) 103
5.4.3.3 Internet of things (IoT) 104
5.5 INDUSTRY TRENDS 104
5.5.1 SHIFT TOWARD PERSONALIZED MEDICINE 104
5.5.2 AI IN DIAGNOSTICS AND IMAGING 104
5.6 PRICING ANALYSIS 105
5.6.1 INDICATIVE PRICING OF AI IN HEALTHCARE SOFTWARE, BY DEPLOYMENT MODEL (QUALITATIVE) 106
5.6.2 INDICATIVE PRICE TREND, BY REGION 106
5.7 VALUE CHAIN ANALYSIS 107
5.8 ECOSYSTEM ANALYSIS 109
5.9 PATENT ANALYSIS 111
5.10 KEY CONFERENCES & EVENTS, 2024–2025 115
5.11 CASE STUDY ANALYSIS 118
5.11.1 BIOBEAT LAUNCHED HOME-BASED REMOTE PATIENT MONITORING KIT DURING PEAK WAVE OF COVID-19 118
5.11.2 MICROSOFT COLLABORATED WITH CLEVELAND CLINIC TO APPLY PREDICTIVE AND ADVANCED ANALYTICS TO IDENTIFY POTENTIAL AT-RISK PATIENTS UNDER ICU CARE 119
5.11.3 TGEN COLLABORATED WITH INTEL CORPORATION AND DELL TECHNOLOGIES TO ASSIST PHYSICIANS AND RESEARCHERS IN ACCELERATING DIAGNOSIS AND TREATMENT AT LOWER COSTS 119
5.11.4 GE HEALTHCARE IMPROVED PATIENT OUTCOMES BY REDUCING WORKFLOW PROCESSING TIME USING MEDICAL IMAGING DATA 120
5.12 REGULATORY LANDSCAPE 120
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121
5.12.2 REGULATORY FRAMEWORK 123
5.12.2.1 North America 123
5.12.2.2 Europe 125
5.12.2.3 Asia Pacific 125
5.12.2.4 Middle East & Africa 126
5.12.2.5 Latin America 127
5.13 PORTER’S FIVE FORCES ANALYSIS 127
5.13.1 THREAT OF NEW ENTRANTS 128
5.13.2 THREAT OF SUBSTITUTES 129
5.13.3 BARGAINING POWER OF SUPPLIERS 129
5.13.4 BARGAINING POWER OF BUYERS 129
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 129
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 130
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 130
5.14.2 BUYING CRITERIA 131
5.15 END-USER ANALYSIS 132
5.15.1 UNMET NEEDS 132
5.15.2 END-USER EXPECTATIONS 133
5.16 AI IN HEALTHCARE BUSINESS MODELS 134
5.16.1 SOFTWARE-AS-A-SERVICE (SAAS) MODEL 134
5.16.2 LICENSING MODEL 134
5.16.3 REVENUE SHARING/OUTCOME-BASED MODEL 134
5.16.4 FREEMIUM MODEL 134
5.16.5 AI-AS-A-SERVICE (AIAAS) MODEL 135
5.16.6 PARTNERSHIP/REVENUE-SHARING MODEL 135
5.16.7 HYBRID MODELS 135
5.16.8 PAY-PER-USE MODELS 135
5.17 INVESTMENT & FUNDING SCENARIO 135
5.18 IMPACT OF GENERATIVE AI ON AI IN HEALTHCARE MARKET 136
5.18.1 INTRODUCTION 136
5.18.2 MARKET POTENTIAL OF GEN AI IN HEALTHCARE 136
5.18.2.1 Key use cases of Gen AI 137
5.18.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 138
5.18.3.1 Eka Care leveraging generative AI for improved health outcomes 138
5.18.4 INTERCONNECTED AND ADJACENT ECOSYSTEMS 139
5.18.4.1 AI in healthcare IT 139
5.18.4.2 AI in medical diagnostics 140
5.18.4.3 AI in oncology 140
5.18.4.4 AI in clinical trials 141
5.18.4.5 AI in drug discovery 141
5.18.5 USER READINESS & IMPACT ASSESSMENT 141
5.18.5.1 User readiness 141
5.18.5.1.1 Healthcare providers 141
5.18.5.1.2 Healthcare payers 142
5.18.5.1.3 Patients 142
5.18.5.2 Impact assessment 143
5.18.5.2.1 User A: Healthcare providers 143
5.18.5.2.1.1 Implementation 143
5.18.5.2.1.2 Impact 143
5.18.5.2.2 User B: Healthcare payers 143
5.18.5.2.2.1 Implementation 143
5.18.5.2.2.2 Impact 143
5.18.5.2.3 User C: Patients 144
5.18.5.2.3.1 Implementation 144
5.18.5.2.3.2 Impact 144
6 AI IN HEALTHCARE MARKET, BY OFFERING 145
6.1 INTRODUCTION 146
6.2 INTEGRATED SOLUTIONS 146
6.2.1 RISING WORKFORCE CHALLENGES AND COST PRESSURES TO DRIVE ADOPTION 146
6.3 NICHE/POINT SOLUTIONS 147
6.3.1 TARGETED AI SOLUTIONS TRANSFORMING PRECISION CARE AND EFFICIENCY IN HEALTHCARE TO BOOST MARKET 147
6.4 AI TECHNOLOGIES 148
6.4.1 ABILITY OF CORE AI TECHNOLOGIES TO DRIVE PRECISION, EFFICIENCY, AND INNOVATION TO SUPPORT MARKET GROWTH 148
6.5 SERVICES 149
6.5.1 NEED FOR EMPOWERING NON-CLINICAL HEALTHCARE OPERATIONS TO ACCELERATE MARKET GROWTH 149
7 AI IN HEALTHCARE MARKET, BY FUNCTION 151
7.1 INTRODUCTION 152
7.2 DIAGNOSIS & EARLY DETECTION 152
7.2.1 PRE-SCREENING 154
7.2.1.1 Early detection, better outcomes, and cost-effective care associated with pre-screening to boost market 154
7.2.2 IVD 154
7.2.2.1 IVD market: By technology 155
7.2.2.1.1 Immunoassays 156
7.2.2.1.1.1 Increasing focus on individualized therapies to drive market 156
7.2.2.1.2 Clinical chemistry 156
7.2.2.1.2.1 Increased demand for precision medicine and efficient healthcare systems to drive market 156
7.2.2.1.3 Molecular diagnostics 157
7.2.2.1.3.1 Improved disease detection, personalized treatments, and enhanced outcomes to fuel growth 157
7.2.2.2 IVD market: By application 158
7.2.2.2.1 Image analysis & interpretation 158
7.2.2.2.1.1 Advantages such as enhanced diagnostic accuracy, faster detection, and improved patient outcomes to support growth 158
7.2.2.2.2 Biomarker discovery & analysis 159
7.2.2.2.2.1 Ability of AI-based biomarker discovery to enhance disease detection, prognosis, and personalized treatment to drive adoption 159
7.2.2.2.3 Other IVD applications 160
7.2.3 DIAGNOSTIC IMAGING 160
7.2.3.1 Diagnostic imaging market: By application 161
7.2.3.1.1 Disease interpretation & report analysis 162
7.2.3.1.1.1 Ability of AI-driven disease interpretation to accelerate diagnosis, treatment, and outcomes to fuel growth 162
7.2.3.1.2 Image captioning & annotation 162
7.2.3.1.2.1 Enhanced diagnostic accuracy, efficiency, and consistency associated with image captioning & annotation to boost market 162
7.2.3.1.3 Image reconstruction 163
7.2.3.1.3.1 Improved diagnostic precision, efficiency, and image quality in healthcare to drive market 163
7.2.3.1.4 Other diagnostic imaging applications 164
7.2.3.2 Diagnostic imaging market: By modality 164
7.2.3.2.1 Magnetic resonance imaging (MRI) 165
7.2.3.2.1.1 Rising technological advancements to drive adoption of AI in MRI 165
7.2.3.2.2 Computed tomography (CT) 166
7.2.3.2.2.1 Rising availability of cardiac CT devices enabled with AI solutions to drive market 166
7.2.3.2.3 X-ray imaging 167
7.2.3.2.3.1 Innovative AI solutions for X-ray imaging by key players to drive market 167
7.2.3.2.4 Ultrasound 168
7.2.3.2.4.1 Increasing prevalence of ovarian cancer to drive market 168
7.2.3.2.5 Nuclear imaging (PET & SPECT) 169
7.2.3.2.5.1 Critical role played by PET and SPECT in visualizing metabolic processes to contribute to growth 169
7.2.3.2.6 Other diagnostic imaging modalities 169
7.2.4 RISK ASSESSMENT & PATIENT STRATIFICATION 170
7.2.4.1 AI-driven risk assessment and patient stratification to enhance healthcare efficiency, outcomes, and personalized care 170
7.2.5 DRUG ALLERGY ALERTING 171
7.2.5.1 Ability of AI-enhanced drug allergy alerting to improve accuracy, patient safety, and personalized care in healthcare to boost market 171
7.2.6 OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS 172
7.3 TREATMENT PLANNING & PERSONALIZATION 173
7.3.1 PERSONALIZED TREATMENT PLANNING 174
7.3.1.1 Precision medicine & genomic analysis 175
7.3.1.1.1 Advantages such as accurate disease predictions and improved outcomes to drive demand 175
7.3.1.2 Predictive models for treatment response 176
7.3.1.2.1 Ability to personalize therapies, improve outcomes, and minimize adverse effects to fuel growth 176
7.3.1.3 Treatment recommendation systems 177
7.3.1.3.1 Optimized healthcare delivery associated with treatment recommendation systems to support growth 177
7.3.2 PHARMACOLOGICAL THERAPY 178
7.3.2.1 Drug response prediction 179
7.3.2.1.1 Growing use of drug response prediction to minimize adverse reactions to aid growth 179
7.3.2.2 Dosing & administration 179
7.3.2.2.1 Improved efficacy and outcomes to fuel adoption 179
7.3.2.3 Other pharmacological therapy functions 180
7.3.3 SURGICAL THERAPY 181
7.3.3.1 Preoperative imaging & 3D modeling 182
7.3.3.1.1 Enhanced surgical planning and precision to propel market 182
7.3.3.2 Intraoperative guidance & robotics 182
7.3.3.2.1 Faster recovery time to boost adoption 182
7.3.3.3 Postoperative analysis & recovery 183
7.3.3.3.1 Reduced complications to drive market 183
7.3.4 RADIATION THERAPY 184
7.3.4.1 Motion synchronization & auto contouring 185
7.3.4.1.1 Optimized radiation therapy with motion synchronization & auto contouring to boost market 185
7.3.4.2 Real-time adaptive treatment delivery 186
7.3.4.2.1 Reduced side effects to propel demand 186
7.3.4.3 Response assessment & quality assurance 186
7.3.4.3.1 Ability of AI to enhance response assessment and QA to spur growth 186
7.3.4.4 Other radiation therapy functions 187
7.3.5 BEHAVIORAL THERAPY & PSYCHOTHERAPY 188
7.3.5.1 Virtual counseling & chatbots 189
7.3.5.1.1 Ability to engage patients remotely to drive market demand 189
7.3.5.2 Progress monitoring & feedback 189
7.3.5.2.1 Increasing use of smart wearables and mobile health apps to drive market 189
7.3.5.3 Follow-up & long-term support 190
7.3.5.3.1 Widespread adoption of telemedicine platforms to drive market demand 190
7.3.6 IMMUNOTHERAPY 191
7.3.6.1 Real-time patient data monitoring 192
7.3.6.1.1 Need for real-time data analysis to make informed decisions to boost market growth 192
7.3.6.2 Response & side-effect prediction 193
7.3.6.2.1 Ability to reduce trial and error approach in medical treatments to drive market growth 193
7.3.6.3 Relapse prediction & long-term management 193
7.3.6.3.1 Need for proactive approach for long-term care to fuel market growth 193
7.3.7 OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS 194
7.4 PATIENT ENGAGEMENT & REMOTE MONITORING 195
7.4.1 SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE 196
7.4.1.1 Rising prevalence of chronic diseases to drive market growth 196
7.4.2 TELEHEALTH & REMOTE PATIENT MONITORING 197
7.4.2.1 Ability to monitor and evaluate patients remotely to boost market demand 197
7.4.3 HEALTHCARE ASSISTANCE ROBOTS 197
7.4.3.1 Advancements in robotics and artificial intelligence (AI) to boost market demand 197
7.4.4 MEDICATION REMINDERS 198
7.4.4.1 Increasing adoption of smartphone applications and IoT devices to surge market demand 198
7.4.5 PATIENT EDUCATION & EMPOWERMENT 199
7.4.5.1 Need to improve treatment adherence and enhance self-management to drive market growth 199
7.4.6 OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS 200
7.5 POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE 201
7.5.1 RECURRENCE MONITORING 202
7.5.1.1 Need to predict recurrence of cancer to drive market 202
7.5.2 LONG-TERM OUTCOME PREDICTION 202
7.5.2.1 Ability to predict long-term health outcomes and enhance patient care to drive market 202
7.5.3 MENTAL HEALTH & SUPPORT SYSTEMS 203
7.5.3.1 Need to help patients cope with mental strain to drive market 203
7.6 PHARMACY MANAGEMENT 204
7.6.1 EPRESCRIBING 205
7.6.1.1 Need to improve safety and efficiency in prescribing to drive market 205
7.6.2 MEDICATION MANAGEMENT 205
7.6.2.1 Ability to predict adverse drug reactions by patient data analysis to drive market 205
7.6.3 PHARMACY AUDIT & ANALYSIS 206
7.6.3.1 Need for effective and efficient operation of pharmacies to drive market 206
7.6.4 OTHER PHARMACY MANAGEMENT FUNCTIONS 207
7.7 DATA MANAGEMENT & ANALYTICS 208
7.7.1 ABILITY OF DATA MANAGEMENT & ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS MAKE INFORMED DECISIONS TO BOOST MARKET 208
7.8 ADMINISTRATIVE 208
7.8.1 PATIENT REGISTRATION & SCHEDULING 210
7.8.1.1 Need to optimize patient registration process to drive market 210
7.8.2 PATIENT ELIGIBILITY & AUTHORIZATION 211
7.8.2.1 Need to reduce administrative burden to drive market 211
7.8.3 BILLING & CLAIMS MANAGEMENT 212
7.8.3.1 Need to make billing process more accurate, efficient, and transparent to drive market 212
7.8.4 WORKFORCE MANAGEMENT 213
7.8.4.1 Need for effective staff management to drive market 213
7.8.5 SUPPLY CHAIN & INVENTORY MANAGEMENT 214
7.8.5.1 Ability to make better procurement decisions to drive market 214
7.8.6 COMPLIANCE & DOCUMENTATION 215
7.8.6.1 Need to reduce manual paperwork and errors to drive market 215
7.8.7 HEALTHCARE WORKFLOW MANAGEMENT 216
7.8.7.1 Need to optimize and automate processes within healthcare facilities to drive market 216
7.8.8 ASSET MANAGEMENT 217
7.8.8.1 Ability to optimize use and allocation of resources to drive market 217
7.8.9 CUSTOMER RELATIONSHIP MANAGEMENT 218
7.8.9.1 Enhancing patient engagement and retention through AI-driven CRM systems to boost market 218
7.8.10 FRAUD DETECTION & RISK MANAGEMENT 219
7.8.10.1 Need to enhance security in healthcare systems to drive market demand 219
7.8.11 CYBERSECURITY 220
7.8.11.1 Enhancing healthcare cybersecurity with AI-driven threat detection and risk management to fuel growth 220
7.8.12 OTHER ADMINISTRATIVE FUNCTIONS 221
8 AI IN HEALTHCARE MARKET, BY APPLICATION 222
8.1 INTRODUCTION 223
8.2 CLINICAL APPLICATIONS 223
8.2.1 ABILITY OF AI TO IMPROVE DIAGNOSTICS, TREATMENT, AND PATIENT CARE TO DRIVE MARKET GROWTH 223
8.3 NON-CLINICAL APPLICATIONS 225
8.3.1 ABILITY OF AI TO REDUCE ADMINISTRATIVE BURDENS AND ENSURE BETTER RESOURCE ALLOCATION TO FUEL GROWTH 225
9 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL 227
9.1 INTRODUCTION 228
9.2 ON-PREMISE MODELS 228
9.2.1 ENHANCED DATA SECURITY AND COMPLIANCE TO PROPEL ADOPTION OF ON-PREMISE AI MODELS 228
9.3 CLOUD-BASED MODELS 229
9.3.1 SCALABILITY AND AUTOMATION OF CLOUD-BASED AI PLATFORMS TO RESHAPE HEALTHCARE DELIVERY GLOBALLY 229
9.4 HYBRID MODELS 231
9.4.1 FLEXIBILITY FOR DIVERSE APPLICATIONS TO BOOST DEMAND FOR HYBRID MODELS 231
10 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TOOL 232
10.1 INTRODUCTION 233
10.2 MACHINE LEARNING 233
10.2.1 DEEP LEARNING 235
10.2.1.1 Convolutional neural networks (CNN) 237
10.2.1.1.1 Growing demand for advance medical imaging and diagnostics to drive market growth 237
10.2.1.2 Recurrent neural networks (RNN) 238
10.2.1.2.1 Ability of RNN to enhance predictive analytics in healthcare to boost market 238
10.2.1.3 Generative adversarial networks (GAN) 238
10.2.1.3.1 Ability to transform data scarcity and privacy in AI-driven healthcare to drive demand for GAN 238
10.2.1.4 Graph neural networks (GNN) 239
10.2.1.4.1 Ability of GNN to revolutionize relational insights in healthcare analytics to fuel growth 239
10.2.1.5 Other deep learning tools 240
10.2.2 SUPERVISED LEARNING 240
10.2.2.1 Need to drive precision and efficiency in healthcare to support adoption of supervised learning tools 240
10.2.3 REINFORCEMENT LEARNING 241
10.2.3.1 Wide usage of reinforcement learning models for real-time and adaptive healthcare solutions to support market growth 241
10.2.4 UNSUPERVISED LEARNING 242
10.2.4.1 Ability of unsupervised learning to drive innovation in healthcare analytics to propel market 242
10.2.5 OTHER MACHINE LEARNING TOOLS 243
10.3 NATURAL LANGUAGE PROCESSING (NLP) 244
10.3.1 SENTIMENT ANALYSIS 245
10.3.1.1 Enhanced patient experience and operational insights to spur demand for sentiment analysis 245
10.3.2 PATTERN & IMAGE RECOGNITION 246
10.3.2.1 Increased precision in clinical decision-making associated with pattern & image recognition to aid market 246
10.3.3 AUTO CODING 246
10.3.3.1 Advantages such as improved medical billing and administrative efficiency to boost market 246
10.3.4 CLASSIFICATION & CATEGORIZATION 247
10.3.4.1 Ability of classification & categorization to organize healthcare data for better outcomes to propel market 247
10.3.5 TEXT ANALYTICS 248
10.3.5.1 Ability to transform unstructured data into actionable healthcare insights to fuel growth 248
10.3.6 SPEECH RECOGNITION 248
10.3.6.1 Improved speech recognition advancing real-time documentation and accessibility to drive demand 248
10.4 CONTEXT-AWARE COMPUTING 249
10.4.1 DEVICE CONTEXT 250
10.4.1.1 Real-time monitoring and decision-making to contribute to market growth 250
10.4.2 USER CONTEXT 251
10.4.2.1 Personalized healthcare and adaptive workflows to drive demand 251
10.4.3 PHYSICAL CONTEXT 252
10.4.3.1 Location-based services associated with physical context to generate demand 252
10.5 GENERATIVE AI 253
10.5.1 ABILITY OF GENERATIVE AI MODELS TO MIMIC DISEASE PROGRESSION TO DRIVE MARKET 253
10.6 COMPUTER VISION 254
10.6.1 ABILITY TO DETECT ABNORMALITIES SUCH AS TUMORS TO FUEL ADOPTION 254
10.7 IMAGE ANALYSIS 255
10.7.1 STREAMLINING DOCUMENT MANAGEMENT TO PROPEL MARKET 255
11 AI IN HEALTHCARE MARKET, BY END USER 257
11.1 INTRODUCTION 258
11.2 HEALTHCARE PROVIDERS 258
11.2.1 HOSPITALS & CLINICS 261
11.2.1.1 Growing need to improve profitability of healthcare to drive use of AI-based healthcare solutions in hospitals 261
11.2.2 AMBULATORY CARE CENTERS 262
11.2.2.1 Supportive government norms and incentives for HCIT solutions and services to drive market growth 262
11.2.3 HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES 263
11.2.3.1 Growing need for long-term home care to drive market growth 263
11.2.4 DIAGNOSTIC & IMAGING CENTERS 264
11.2.4.1 Growing burden of various chronic diseases to propel market growth 264
11.2.5 PHARMACIES 266
11.2.5.1 Advantages of workflow improvements and error reduction to drive AI-based healthcare solution adoption in pharmacies 266
11.2.6 OTHER HEALTHCARE PROVIDERS 267
11.3 HEALTHCARE PAYERS 267
11.3.1 PUBLIC PAYERS 268
11.3.1.1 Focus on developing outcome-based payment models to drive demand for payer solutions 268
11.3.2 PRIVATE PAYERS 269
11.3.2.1 Possible increases in operational efficiency to boost demand among private payers 269
11.4 PATIENTS 270
11.4.1 RISE IN USE OF AI IN MENTAL HEALTH SUPPORT APPLICATIONS THROUGH CHATBOTS AND VIRTUAL THERAPISTS TO BOOST MARKET 270
11.5 OTHER END USERS 271
12 AI IN HEALTHCARE MARKET, BY REGION 273
12.1 INTRODUCTION 274
12.2 NORTH AMERICA 275
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 277
12.2.2 US 292
12.2.2.1 Rising adoption of advanced medical imaging and regulatory support to drive market 292
12.2.3 CANADA 307
12.2.3.1 Growing burden of chronic diseases and research grants for AI to drive market growth 307
12.3 EUROPE 322
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 324
12.3.2 GERMANY 339
12.3.2.1 Advanced healthcare system and government efforts to drive growth 339
12.3.3 UK 354
12.3.3.1 Government support and new AI platform emergence to boost market 354
12.3.4 FRANCE 369
12.3.4.1 Thriving AI ecosystem and strategic partnerships to boost healthcare innovation 369
12.3.5 ITALY 384
12.3.5.1 Regulatory reforms, strategic investments, and aging population to propel growth 384
12.3.6 SPAIN 399
12.3.6.1 Established network of research centers to propel market 399
12.3.7 REST OF EUROPE 414
12.4 ASIA PACIFIC 429
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 431
12.4.2 CHINA 446
12.4.2.1 Expanding AI applications in medical imaging and diagnostics to drive market growth 446
12.4.3 JAPAN 461
12.4.3.1 Strong healthcare infrastructure to drive uptake of advanced AI 461
12.4.4 INDIA 476
12.4.4.1 Favorable government initiatives for R&D investments to drive market 476
12.4.5 REST OF ASIA PACIFIC 491
12.5 LATIN AMERICA 506
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 507
12.5.2 BRAZIL 523
12.5.2.1 AI initiatives to drive healthcare innovation and accessibility 523
12.5.3 MEXICO 537
12.5.3.1 AI to revolutionize healthcare delivery and outcomes 537
12.5.4 REST OF LATIN AMERICA 552
12.6 MIDDLE EAST & AFRICA 567
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 568
12.6.2 GCC COUNTRIES 583
12.6.2.1 AI-driven innovations and rising healthcare investments to propel market growth 583
12.6.3 REST OF MIDDLE EAST & AFRICA 598
13 COMPETITIVE LANDSCAPE 614
13.1 INTRODUCTION 614
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 614
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET 614
13.3 REVENUE ANALYSIS, 2019–2023 617
13.4 MARKET SHARE ANALYSIS, 2023 618
13.4.1 RANKING OF KEY MARKET PLAYERS 621
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 621
13.5.1 STARS 621
13.5.2 EMERGING LEADERS 621
13.5.3 PERVASIVE PLAYERS 621
13.5.4 PARTICIPANTS 622
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 623
13.5.5.1 Company footprint 623
13.5.5.2 Region footprint 624
13.5.5.3 Application footprint 625
13.5.5.4 Tool footprint 626
13.5.5.5 Function footprint 627
13.5.5.6 Offering footprint 628
13.5.5.7 Deployment footprint 629
13.5.5.8 End-user footprint 630
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 631
13.6.1 PROGRESSIVE COMPANIES 631
13.6.2 RESPONSIVE COMPANIES 631
13.6.3 DYNAMIC COMPANIES 631
13.6.4 STARTING BLOCKS 631
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 633
13.7 COMPANY VALUATION & FINANCIAL METRICS 634
13.7.1 FINANCIAL METRICS 634
13.7.2 COMPANY VALUATION 634
13.8 BRAND/PRODUCT COMPARISON 635
13.9 COMPETITIVE SCENARIO 636
13.9.1 PRODUCT LAUNCHES 636
13.9.2 DEALS 637
13.9.3 OTHER DEVELOPMENTS 638
14 COMPANY PROFILES 640
14.1 KEY PLAYERS 640
14.1.1 KONINKLIJKE PHILIPS N.V. 640
14.1.1.1 Business overview 640
14.1.1.2 Products & services offered 641
14.1.1.3 Recent developments 644
14.1.1.3.1 Product launches 644
14.1.1.3.2 Deals 645
14.1.1.3.3 Expansions 646
14.1.1.3.4 Other developments 646
14.1.1.4 MnM view 647
14.1.1.4.1 Right to win 647
14.1.1.4.2 Strategic choices 647
14.1.1.4.3 Weaknesses & competitive threats 647
14.1.2 MICROSOFT CORPORATION 648
14.1.2.1 Business overview 648
14.1.2.2 Products & services offered 650
14.1.2.3 Recent developments 651
14.1.2.3.1 Product launches 651
14.1.2.3.2 Deals 652
14.1.2.4 MnM view 654
14.1.2.4.1 Right to win 654
14.1.2.4.2 Strategic choices 654
14.1.2.4.3 Weaknesses & competitive threats 655
14.1.3 NVIDIA CORPORATION 656
14.1.3.1 Business overview 656
14.1.3.2 Products & services offered 657
14.1.3.3 Recent developments 658
14.1.3.3.1 Product launches 658
14.1.3.3.2 Deals 659
14.1.3.4 MnM view 660
14.1.3.4.1 Right to win 660
14.1.3.4.2 Strategic choices 660
14.1.3.4.3 Weaknesses & competitive threats 660
14.1.4 SIEMENS HEALTHINEERS AG 661
14.1.4.1 Business overview 661
14.1.4.2 Products & services offered 663
14.1.4.3 Recent developments 664
14.1.4.3.1 Product launches & enhancements 664
14.1.4.3.2 Deals 664
14.1.4.3.3 Other developments 665
14.1.4.4 MnM view 666
14.1.4.4.1 Right to win 666
14.1.4.4.2 Strategic choices 666
14.1.4.4.3 Weaknesses & competitive threats 666
14.1.5 GE HEALTHCARE 667
14.1.5.1 Business overview 667
14.1.5.2 Products & services offered 669
14.1.5.3 Recent developments 670
14.1.5.3.1 Deals 670
14.1.6 EPIC SYSTEMS CORPORATION 672
14.1.6.1 Business overview 672
14.1.6.2 Products & services offered 672
14.1.6.3 Recent developments 673
14.1.6.3.1 Deals 673
14.1.7 ORACLE 674
14.1.7.1 Business overview 674
14.1.7.2 Products & services offered 676
14.1.7.3 Recent developments 677
14.1.7.3.1 Product launches 677
14.1.7.3.2 Deals 677
14.1.8 VERADIGM LLC 679
14.1.8.1 Business overview 679
14.1.8.2 Products & services offered 680
14.1.8.3 Recent developments 681
14.1.8.3.1 Deals 681
14.1.9 AMAZON WEB SERVICES, INC. 682
14.1.9.1 Business overview 682
14.1.9.2 Products & services offered 683
14.1.9.3 Recent developments 684
14.1.9.3.1 Product launches 684
14.1.9.3.2 Deals 685
14.1.10 MERATIVE (IBM) 686
14.1.10.1 Business overview 686
14.1.10.2 Products & services offered 687
14.1.10.3 Recent developments 688
14.1.10.3.1 Product launches 688
14.1.10.3.2 Deals 689
14.1.11 MEDTRONIC 690
14.1.11.1 Business overview 690
14.1.11.2 Products & services offered 691
14.1.11.3 Recent developments 692
14.1.11.3.1 Deals 692
14.1.12 GOOGLE 693
14.1.12.1 Business overview 693
14.1.12.2 Products & services offered 694
14.1.12.3 Recent developments 695
14.1.12.3.1 Product launches 695
14.1.12.3.2 Deals 696
14.1.12.3.3 Other developments 697
14.1.13 SOPHIA GENETICS 698
14.1.13.1 Business overview 698
14.1.13.2 Products & services offered 699
14.1.13.3 Recent developments 699
14.1.13.3.1 Deals 699
14.1.14 JOHNSON & JOHNSON SERVICES, INC. 700
14.1.14.1 Business overview 700
14.1.14.2 Products & services offered 701
14.1.14.3 Recent developments 702
14.1.14.3.1 Deals 702
14.1.15 TEMPUS 703
14.1.15.1 Business overview 703
14.1.15.2 Products & services offered 704
14.1.15.3 Recent developments 705
14.1.15.3.1 Product launches & approvals 705
14.1.15.3.2 Deals 705
14.1.16 TERARECON (CONCERTAI) 706
14.1.16.1 Business overview 706
14.1.16.2 Products & services offered 706
14.1.16.3 Recent developments 707
14.1.16.3.1 Product launches & upgrades 707
14.1.16.3.2 Deals 708
14.1.17 3M 709
14.1.17.1 Business overview 709
14.1.17.2 Products & services offered 710
14.1.17.3 Recent developments 710
14.1.17.3.1 Deals 710
14.1.18 COGNIZANT 711
14.1.18.1 Business overview 711
14.1.18.2 Products & services offered 712
14.1.18.3 Recent developments 713
14.1.18.3.1 Product launches & upgrades 713
14.1.18.3.2 Deals 714
14.1.19 VIZ.AI, INC. 715
14.1.19.1 Business overview 715
14.1.19.2 Products & services offered 715
14.1.19.3 Recent developments 716
14.1.19.3.1 Product launches 716
14.1.19.3.2 Deals 716
14.1.19.3.3 Other developments 718
14.1.20 RIVERAIN TECHNOLOGIES 719
14.1.20.1 Business overview 719
14.1.20.2 Products & services offered 719
14.1.20.3 Recent developments 720
14.1.20.3.1 Deals 720
14.2 OTHER PLAYERS 721
14.2.1 QVENTUS 721
14.2.2 QURE.AI 722
14.2.3 ATOMWISE INC. 723
14.2.4 ENLITIC 724
14.2.5 SEGMED 725
15 APPENDIX 726
15.1 DISCUSSION GUIDE 726
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 734
15.3 CUSTOMIZATION OPTIONS 736
15.4 RELATED REPORTS 736
15.5 AUTHOR DETAILS 737
LIST OF TABLES
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 63
TABLE 2 AI IN HEALTHCARE MARKET: RISK ASSESSMENT 78
TABLE 3 AI IN HEALTHCARE MARKET: IMPACT ANALYSIS 90
TABLE 4 AI IN HEALTHCARE MARKET: AVERAGE SELLING PRICE, BY REGION (2021–2023) 106
TABLE 5 COMPANIES AND THEIR ROLES IN AI IN HEALTHCARE ECOSYSTEM 110
TABLE 6 AI IN HEALTHCARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS 111
TABLE 7 AI IN HEALTHCARE MARKET: LIST OF CONFERENCES & EVENTS, 2024–2025 115
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 11 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 127
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 130
TABLE 13 KEY BUYING CRITERIA FOR TOP THREE END USERS 131
TABLE 14 UNMET NEEDS IN AI IN HEALTHCARE MARKET 132
TABLE 15 END-USER EXPECTATIONS IN AI IN HEALTHCARE MARKET 133
TABLE 16 AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 146
TABLE 17 AI IN HEALTHCARE MARKET FOR INTEGRATED SOLUTIONS, BY REGION, 2022–2030 (USD MILLION) 147
TABLE 18 AI IN HEALTHCARE MARKET FOR NICHE/POINT SOLUTIONS, BY REGION, 2022–2030 (USD MILLION) 148
TABLE 19 AI IN HEALTHCARE MARKET FOR AI TECHNOLOGIES, BY REGION, 2022–2030 (USD MILLION) 149
TABLE 20 AI IN HEALTHCARE MARKET FOR SERVICES, BY REGION, 2022–2030 (USD MILLION) 150
TABLE 21 AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 152
TABLE 22 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 153
TABLE 23 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 153
TABLE 24 AI IN HEALTHCARE MARKET FOR PRE-SCREENING, BY REGION, 2022–2030 (USD MILLION) 154
TABLE 25 AI IN HEALTHCARE MARKET FOR IVD, BY REGION, 2022–2030 (USD MILLION) 155
TABLE 26 AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 155
TABLE 27 AI IN HEALTHCARE MARKET FOR IMMUNOASSAYS, BY REGION, 2022–2030 (USD MILLION) 156
TABLE 28 AI IN HEALTHCARE MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2022–2030 (USD MILLION) 157
TABLE 29 AI IN HEALTHCARE MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2022–2030 (USD MILLION) 157
TABLE 30 AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 158
TABLE 31 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS & INTERPRETATION, BY REGION, 2022–2030 (USD MILLION) 159
TABLE 32 AI IN HEALTHCARE MARKET FOR BIOMARKER DISCOVERY & ANALYSIS, BY REGION, 2022–2030 (USD MILLION) 159
TABLE 33 AI IN HEALTHCARE MARKET FOR OTHER IVD APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 160
TABLE 34 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY REGION, 2022–2030 (USD MILLION) 161
TABLE 35 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 161
TABLE 36 AI IN HEALTHCARE MARKET FOR DISEASE INTERPRETATION & REPORT ANALYSIS, BY REGION, 2022–2030 (USD MILLION) 162
TABLE 37 AI IN HEALTHCARE MARKET FOR IMAGE CAPTIONING & ANNOTATION, BY REGION, 2022–2030 (USD MILLION) 163
TABLE 38 AI IN HEALTHCARE MARKET FOR IMAGE RECONSTRUCTION, BY REGION, 2022–2030 (USD MILLION) 163
TABLE 39 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 164
TABLE 40 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 165
TABLE 41 AI IN HEALTHCARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2022–2030 (USD MILLION) 166
TABLE 42 AI IN HEALTHCARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY REGION, 2022–2030 (USD MILLION) 167
TABLE 43 AI IN HEALTHCARE MARKET FOR X-RAY IMAGING, BY REGION, 2022–2030 (USD MILLION) 167
TABLE 44 AI IN HEALTHCARE MARKET FOR ULTRASOUND, BY REGION, 2022–2030 (USD MILLION) 168
TABLE 45 AI IN HEALTHCARE MARKET FOR NUCLEAR IMAGING (PET & SPECT), BY REGION, 2022–2030 (USD MILLION) 169
TABLE 46 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING MODALITIES, BY REGION, 2022–2030 (USD MILLION) 170
TABLE 47 AI IN HEALTHCARE MARKET FOR RISK ASSESSMENT & PATIENT STRATIFICATION, BY REGION, 2022–2030 (USD MILLION) 171
TABLE 48 AI IN HEALTHCARE MARKET FOR DRUG ALLERGY ALERTING, BY REGION, 2022–2030 (USD MILLION) 172
TABLE 49 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 172
TABLE 50 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 173
TABLE 51 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 174
TABLE 52 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 174
TABLE 53 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY REGION, 2022–2030 (USD MILLION) 175
TABLE 54 AI IN HEALTHCARE MARKET FOR PRECISION MEDICINE & GENOMIC ANALYSIS, BY REGION, 2022–2030 (USD MILLION) 176
TABLE 55 AI IN HEALTHCARE MARKET FOR PREDICTIVE MODELS FOR TREATMENT RESPONSE, BY REGION, 2022–2030 (USD MILLION) 177
TABLE 56 AI IN HEALTHCARE MARKET FOR TREATMENT RECOMMENDATION SYSTEMS, BY REGION, 2022–2030 (USD MILLION) 177
TABLE 57 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 178
TABLE 58 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY REGION, 2022–2030 (USD MILLION) 178
TABLE 59 AI IN HEALTHCARE MARKET FOR DRUG RESPONSE PREDICTION, BY REGION, 2022–2030 (USD MILLION) 179
TABLE 60 AI IN HEALTHCARE MARKET FOR DOSING & ADMINISTRATION, BY REGION, 2022–2030 (USD MILLION) 180
TABLE 61 AI IN HEALTHCARE MARKET FOR OTHER PHARMACOLOGICAL THERAPY FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 180
TABLE 62 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 181
TABLE 63 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY REGION, 2022–2030 (USD MILLION) 181
TABLE 64 AI IN HEALTHCARE MARKET FOR PREOPERATIVE IMAGING & 3D MODELING, BY REGION, 2022–2030 (USD MILLION) 182
TABLE 65 AI IN HEALTHCARE MARKET FOR INTRAOPERATIVE GUIDANCE & ROBOTICS, BY REGION, 2022–2030 (USD MILLION) 183
TABLE 66 AI IN HEALTHCARE MARKET FOR POSTOPERATIVE ANALYSIS & RECOVERY, BY REGION, 2022–2030 (USD MILLION) 184
TABLE 67 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 184
TABLE 68 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY REGION, 2022–2030 (USD MILLION) 185
TABLE 69 AI IN HEALTHCARE MARKET FOR MOTION SYNCHRONIZATION & AUTO CONTOURING, BY REGION, 2022–2030 (USD MILLION) 185
TABLE 70 AI IN HEALTHCARE MARKET FOR REAL-TIME ADAPTIVE TREATMENT DELIVERY, BY REGION, 2022–2030 (USD MILLION) 186
TABLE 71 AI IN HEALTHCARE MARKET FOR RESPONSE ASSESSMENT & QUALITY ASSURANCE, BY REGION, 2022–2030 (USD MILLION) 187
TABLE 72 AI IN HEALTHCARE MARKET FOR OTHER RADIATION THERAPY FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 187
TABLE 73 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 188
TABLE 74 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY REGION, 2022–2030 (USD MILLION) 188
TABLE 75 AI IN HEALTHCARE MARKET FOR VIRTUAL COUNSELING & CHATBOTS, BY REGION, 2022–2030 (USD MILLION) 189
TABLE 76 AI IN HEALTHCARE MARKET FOR PROGRESS MONITORING & FEEDBACK, BY REGION, 2022–2030 (USD MILLION) 190
TABLE 77 AI IN HEALTHCARE MARKET FOR FOLLOW-UP & LONG-TERM SUPPORT, BY REGION, 2022–2030 (USD MILLION) 191
TABLE 78 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 191
TABLE 79 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY REGION, 2022–2030 (USD MILLION) 192
TABLE 80 AI IN HEALTHCARE MARKET FOR REAL-TIME PATIENT DATA MONITORING, BY REGION, 2022–2030 (USD MILLION) 192
TABLE 81 AI IN HEALTHCARE MARKET FOR RESPONSE & SIDE-EFFECT PREDICTION, BY REGION, 2022–2030 (USD MILLION) 193
TABLE 82 AI IN HEALTHCARE MARKET FOR RELAPSE PREDICTION & LONG-TERM MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 194
TABLE 83 AI IN HEALTHCARE MARKET FOR OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 194
TABLE 84 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 195
TABLE 85 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 196
TABLE 86 AI IN HEALTHCARE MARKET FOR SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE, BY REGION, 2022–2030 (USD MILLION) 196
TABLE 87 AI IN HEALTHCARE MARKET FOR TELEHEALTH & REMOTE PATIENT MONITORING, BY REGION, 2022–2030 (USD MILLION) 197
TABLE 88 AI IN HEALTHCARE MARKET FOR HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2022–2030 (USD MILLION) 198
TABLE 89 AI IN HEALTHCARE MARKET FOR MEDICATION REMINDERS, BY REGION, 2022–2030 (USD MILLION) 199
TABLE 90 AI IN HEALTHCARE MARKET FOR PATIENT EDUCATION & EMPOWERMENT, BY REGION, 2022–2030 (USD MILLION) 200
TABLE 91 AI IN HEALTHCARE MARKET FOR OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 200
TABLE 92 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 201
TABLE 93 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 201
TABLE 94 AI IN HEALTHCARE MARKET FOR RECURRENCE MONITORING, BY REGION, 2022–2030 (USD MILLION) 202
TABLE 95 AI IN HEALTHCARE MARKET FOR LONG-TERM OUTCOME PREDICTION, BY REGION, 2022–2030 (USD MILLION) 203
TABLE 96 AI IN HEALTHCARE MARKET FOR MENTAL HEALTH & SUPPORT SYSTEMS, BY REGION, 2022–2030 (USD MILLION) 203
TABLE 97 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 204
TABLE 98 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 204
TABLE 99 AI IN HEALTHCARE MARKET FOR EPRESCRIBING, BY REGION, 2022–2030 (USD MILLION) 205
TABLE 100 AI IN HEALTHCARE MARKET FOR MEDICATION MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 206
TABLE 101 AI IN HEALTHCARE MARKET FOR PHARMACY AUDIT & ANALYSIS, BY REGION, 2022–2030 (USD MILLION) 207
TABLE 102 AI IN HEALTHCARE MARKET FOR OTHER PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 207
TABLE 103 AI IN HEALTHCARE MARKET FOR DATA MANAGEMENT & ANALYTICS FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 208
TABLE 104 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 209
TABLE 105 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 210
TABLE 106 AI IN HEALTHCARE MARKET FOR PATIENT REGISTRATION & SCHEDULING, BY REGION, 2022–2030 (USD MILLION) 211
TABLE 107 AI IN HEALTHCARE MARKET FOR PATIENT ELIGIBILITY & AUTHORIZATION, BY REGION, 2022–2030 (USD MILLION) 212
TABLE 108 AI IN HEALTHCARE MARKET FOR BILLING & CLAIMS MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 213
TABLE 109 AI IN HEALTHCARE MARKET FOR WORKFORCE MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 214
TABLE 110 AI IN HEALTHCARE MARKET FOR SUPPLY CHAIN & INVENTORY MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 215
TABLE 111 AI IN HEALTHCARE MARKET FOR COMPLIANCE & DOCUMENTATION, BY REGION, 2022–2030 (USD MILLION) 216
TABLE 112 AI IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 217
TABLE 113 AI IN HEALTHCARE MARKET FOR ASSET MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 218
TABLE 114 AI IN HEALTHCARE MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 219
TABLE 115 AI IN HEALTHCARE MARKET FOR FRAUD DETECTION & RISK MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 220
TABLE 116 AI IN HEALTHCARE MARKET FOR CYBERSECURITY, BY REGION, 2022–2030 (USD MILLION) 221
TABLE 117 AI IN HEALTHCARE MARKET FOR OTHER ADMINISTRATIVE FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 221
TABLE 118 AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 223
TABLE 119 AI IN HEALTHCARE MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 224
TABLE 120 AI IN HEALTHCARE MARKET FOR NON-CLINICAL APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 226
TABLE 121 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 228
TABLE 122 AI IN HEALTHCARE MARKET FOR ON-PREMISE MODELS, BY REGION, 2022–2030 (USD MILLION) 229
TABLE 123 AI IN HEALTHCARE MARKET FOR CLOUD-BASED MODELS, BY REGION, 2022–2030 (USD MILLION) 230
TABLE 124 AI IN HEALTHCARE MARKET FOR HYBRID MODELS, BY REGION, 2022–2030 (USD MILLION) 231
TABLE 125 AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 233
TABLE 126 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 234
TABLE 127 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY REGION, 2022–2030 (USD MILLION) 235
TABLE 128 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 236
TABLE 129 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION, 2022–2030 (USD MILLION) 237
TABLE 130 AI IN HEALTHCARE MARKET FOR CONVULATIONAL NEURAL NETWORKS (CNN), BY REGION, 2022–2030 (USD MILLION) 237
TABLE 131 AI IN HEALTHCARE MARKET FOR RECURRENT NEURAL NETWORKS (RNN), BY REGION, 2022–2030 (USD MILLION) 238
TABLE 132 AI IN HEALTHCARE MARKET FOR GENERATIVE ADVERSARIAL NETWORKS (GAN), BY REGION, 2022–2030 (USD MILLION) 239
TABLE 133 AI IN HEALTHCARE MARKET FOR GRAPH NEURAL NETWORKS (GNN), BY REGION, 2022–2030 (USD MILLION) 239
TABLE 134 AI IN HEALTHCARE MARKET FOR OTHER DEEP LEARNING TOOLS, BY REGION, 2022–2030 (USD MILLION) 240
TABLE 135 AI IN HEALTHCARE MARKET FOR SUPERVISED LEARNING, BY REGION, 2022–2030 (USD MILLION) 241
TABLE 136 AI IN HEALTHCARE MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2022–2030 (USD MILLION) 242
TABLE 137 AI IN HEALTHCARE MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2022–2030 (USD MILLION) 243
TABLE 138 AI IN HEALTHCARE MARKET FOR OTHER MACHINE LEARNING TOOLS, BY REGION, 2022–2030 (USD MILLION) 243
TABLE 139 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY TYPE, 2022–2030 (USD MILLION) 244
TABLE 140 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY REGION, 2022–2030 (USD MILLION) 245
TABLE 141 AI IN HEALTHCARE MARKET FOR SENTIMENT ANALYSIS, BY REGION, 2022–2030 (USD MILLION) 245
TABLE 142 AI IN HEALTHCARE MARKET FOR PATTERN & IMAGE RECOGNITION, BY REGION, 2022–2030 (USD MILLION) 246
TABLE 143 AI IN HEALTHCARE MARKET FOR AUTO CODING, BY REGION, 2022–2030 (USD MILLION) 247
TABLE 144 AI IN HEALTHCARE MARKET FOR CLASSIFICATION & CATEGORIZATION, BY REGION, 2022–2030 (USD MILLION) 247
TABLE 145 AI IN HEALTHCARE MARKET FOR TEXT ANALYTICS, BY REGION, 2022–2030 (USD MILLION) 248
TABLE 146 AI IN HEALTHCARE MARKET FOR SPEECH RECOGNITION, BY REGION, 2022–2030 (USD MILLION) 249
TABLE 147 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 250
TABLE 148 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY REGION, 2022–2030 (USD MILLION) 250
TABLE 149 AI IN HEALTHCARE MARKET FOR DEVICE CONTEXT, BY REGION, 2022–2030 (USD MILLION) 251
TABLE 150 AI IN HEALTHCARE MARKET FOR USER CONTEXT, BY REGION, 2022–2030 (USD MILLION) 252
TABLE 151 AI IN HEALTHCARE MARKET FOR PHYSICAL CONTEXT, BY REGION, 2022–2030 (USD MILLION) 253
TABLE 152 AI IN HEALTHCARE MARKET FOR GENERATIVE AI, BY REGION, 2022–2030 (USD MILLION) 254
TABLE 153 AI IN HEALTHCARE MARKET FOR COMPUTER VISION, BY REGION, 2022–2030 (USD MILLION) 255
TABLE 154 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS, BY REGION, 2022–2030 (USD MILLION) 256
TABLE 155 AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 258
TABLE 156 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 260
TABLE 157 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION) 260
TABLE 158 AI IN HEALTHCARE MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION) 262
TABLE 159 AI IN HEALTHCARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2022–2030 (USD MILLION) 263
TABLE 160 AI IN HEALTHCARE MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION) 264
TABLE 161 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2022–2030 (USD MILLION) 265
TABLE 162 AI IN HEALTHCARE MARKET FOR PHARMACIES, BY REGION, 2022–2030 (USD MILLION) 266
TABLE 163 AI IN HEALTHCARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION) 267
TABLE 164 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 268
TABLE 165 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION) 268
TABLE 166 AI IN HEALTHCARE MARKET FOR PUBLIC PAYERS, BY REGION, 2022–2030 (USD MILLION) 269
TABLE 167 AI IN HEALTHCARE MARKET FOR PRIVATE PAYERS, BY REGION, 2022–2030 (USD MILLION) 270
TABLE 168 AI IN HEALTHCARE MARKET FOR PATIENTS, BY REGION, 2022–2030 (USD MILLION) 271
TABLE 169 AI IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION) 272
TABLE 170 AI IN HEALTHCARE MARKET, BY REGION, 2022–2030 (USD MILLION) 274
TABLE 171 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 277
TABLE 172 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 278
TABLE 173 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 278
TABLE 174 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 279
TABLE 175 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 279
TABLE 176 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 280
TABLE 177 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 280
TABLE 178 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 281
TABLE 179 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 281
TABLE 180 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 282
TABLE 181 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 282
TABLE 182 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 283
TABLE 183 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 283
TABLE 184 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 284
TABLE 185 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 284
TABLE 186 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 285
TABLE 187 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 285
TABLE 188 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 286
TABLE 189 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 287
TABLE 190 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 288
TABLE 191 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 288
TABLE 192 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 289
TABLE 193 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 289
TABLE 194 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 290
TABLE 195 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 290
TABLE 196 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 291
TABLE 197 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 291
TABLE 198 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 292
TABLE 199 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 292
TABLE 200 US: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 293
TABLE 201 US: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 294
TABLE 202 US: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 294
TABLE 203 US: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 295
TABLE 204 US: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 295
TABLE 205 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 296
TABLE 206 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 296
TABLE 207 US: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 297
TABLE 208 US: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 297
TABLE 209 US: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 298
TABLE 210 US: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 298
TABLE 211 US: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 299
TABLE 212 US: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 299
TABLE 213 US: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 300
TABLE 214 US: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 300
TABLE 215 US: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 301
TABLE 216 US: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 301
TABLE 217 US: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 302
TABLE 218 US: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 302
TABLE 219 US: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 303
TABLE 220 US: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 303
TABLE 221 US: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 304
TABLE 222 US: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 304
TABLE 223 US: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 305
TABLE 224 US: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 305
TABLE 225 US: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 306
TABLE 226 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 306
TABLE 227 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 307
TABLE 228 CANADA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 308
TABLE 229 CANADA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 308
TABLE 230 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 309
TABLE 231 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 309
TABLE 232 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 310
TABLE 233 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 310
TABLE 234 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 311
TABLE 235 CANADA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 311
TABLE 236 CANADA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 312
TABLE 237 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 312
TABLE 238 CANADA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 313
TABLE 239 CANADA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 313
TABLE 240 CANADA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 314
TABLE 241 CANADA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 314
TABLE 242 CANADA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 315
TABLE 243 CANADA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 315
TABLE 244 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 316
TABLE 245 CANADA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 317
TABLE 246 CANADA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 317
TABLE 247 CANADA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 318
TABLE 248 CANADA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 318
TABLE 249 CANADA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 319
TABLE 250 CANADA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 319
TABLE 251 CANADA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 320
TABLE 252 CANADA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 320
TABLE 253 CANADA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 321
TABLE 254 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 321
TABLE 255 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 322
TABLE 256 EUROPE: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 324
TABLE 257 EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 325
TABLE 258 EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 325
TABLE 259 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 326
TABLE 260 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 326
TABLE 261 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 327
TABLE 262 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 327
TABLE 263 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 328
TABLE 264 EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 328
TABLE 265 EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 329
TABLE 266 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 329
TABLE 267 EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 330
TABLE 268 EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 330
TABLE 269 EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 331
TABLE 270 EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 331
TABLE 271 EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 332
TABLE 272 EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 332
TABLE 273 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 333
TABLE 274 EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 334
TABLE 275 EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 334
TABLE 276 EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 335
TABLE 277 EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 335
TABLE 278 EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 336
TABLE 279 EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 336
TABLE 280 EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 337
TABLE 281 EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 337
TABLE 282 EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 338
TABLE 283 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 338
TABLE 284 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 339
TABLE 285 GERMANY: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 340
TABLE 286 GERMANY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 340
TABLE 287 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 341
TABLE 288 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 341
TABLE 289 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 342
TABLE 290 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 342
TABLE 291 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 343
TABLE 292 GERMANY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 343
TABLE 293 GERMANY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 344
TABLE 294 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 344
TABLE 295 GERMANY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 345
TABLE 296 GERMANY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 345
TABLE 297 GERMANY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 346
TABLE 298 GERMANY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 346
TABLE 299 GERMANY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 347
TABLE 300 GERMANY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 347
TABLE 301 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 348
TABLE 302 GERMANY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 349
TABLE 303 GERMANY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 349
TABLE 304 GERMANY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 350
TABLE 305 GERMANY: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 350
TABLE 306 GERMANY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 351
TABLE 307 GERMANY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 351
TABLE 308 GERMANY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 352
TABLE 309 GERMANY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 352
TABLE 310 GERMANY: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 353
TABLE 311 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 353
TABLE 312 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 354
TABLE 313 UK: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 355
TABLE 314 UK: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 355
TABLE 315 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 356
TABLE 316 UK: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 356
TABLE 317 UK: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 357
TABLE 318 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 357
TABLE 319 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 358
TABLE 320 UK: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 358
TABLE 321 UK: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 359
TABLE 322 UK: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 359
TABLE 323 UK: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 360
TABLE 324 UK: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 360
TABLE 325 UK: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 361
TABLE 326 UK: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 361
TABLE 327 UK: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 362
TABLE 328 UK: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 362
TABLE 329 UK: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 363
TABLE 330 UK: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 364
TABLE 331 UK: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 364
TABLE 332 UK: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 365
TABLE 333 UK: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 365
TABLE 334 UK: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 366
TABLE 335 UK: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 366
TABLE 336 UK: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 367
TABLE 337 UK: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 367
TABLE 338 UK: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 368
TABLE 339 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 368
TABLE 340 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 369
TABLE 341 FRANCE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 370
TABLE 342 FRANCE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 370
TABLE 343 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 371
TABLE 344 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 371
TABLE 345 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 372
TABLE 346 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 372
TABLE 347 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 373
TABLE 348 FRANCE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 373
TABLE 349 FRANCE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 374
TABLE 350 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 374
TABLE 351 FRANCE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 375
TABLE 352 FRANCE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 375
TABLE 353 FRANCE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 376
TABLE 354 FRANCE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 376
TABLE 355 FRANCE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 377
TABLE 356 FRANCE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 378
TABLE 357 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 378
TABLE 358 FRANCE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 379
TABLE 359 FRANCE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 379
TABLE 360 FRANCE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 380
TABLE 361 FRANCE: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 380
TABLE 362 FRANCE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 381
TABLE 363 FRANCE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 381
TABLE 364 FRANCE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 382
TABLE 365 FRANCE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 382
TABLE 366 FRANCE: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 383
TABLE 367 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 383
TABLE 368 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 384
TABLE 369 ITALY: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 385
TABLE 370 ITALY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 385
TABLE 371 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 386
TABLE 372 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 386
TABLE 373 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 387
TABLE 374 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 387
TABLE 375 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 388
TABLE 376 ITALY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 388
TABLE 377 ITALY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 389
TABLE 378 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 389
TABLE 379 ITALY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 390
TABLE 380 ITALY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 390
TABLE 381 ITALY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 391
TABLE 382 ITALY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 391
TABLE 383 ITALY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 392
TABLE 384 ITALY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 393
TABLE 385 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 393
TABLE 386 ITALY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 394
TABLE 387 ITALY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 394
TABLE 388 ITALY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 395
TABLE 389 ITALY: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 395
TABLE 390 ITALY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 396
TABLE 391 ITALY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 396
TABLE 392 ITALY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 397
TABLE 393 ITALY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 397
TABLE 394 ITALY: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 398
TABLE 395 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 398
TABLE 396 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 399
TABLE 397 SPAIN: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 400
TABLE 398 SPAIN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 400
TABLE 399 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 401
TABLE 400 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 401
TABLE 401 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 402
TABLE 402 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 402
TABLE 403 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 403
TABLE 404 SPAIN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 403
TABLE 405 SPAIN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 404
TABLE 406 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 404
TABLE 407 SPAIN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 405
TABLE 408 SPAIN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 405
TABLE 409 SPAIN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 406
TABLE 410 SPAIN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 406
TABLE 411 SPAIN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 407
TABLE 412 SPAIN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 408
TABLE 413 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 408
TABLE 414 SPAIN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 409
TABLE 415 SPAIN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 409
TABLE 416 SPAIN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 410
TABLE 417 SPAIN: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 410
TABLE 418 SPAIN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 411
TABLE 419 SPAIN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 411
TABLE 420 SPAIN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 412
TABLE 421 SPAIN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 412
TABLE 422 SPAIN: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 413
TABLE 423 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 413
TABLE 424 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 414
TABLE 425 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 415
TABLE 426 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 415
TABLE 427 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 416
TABLE 428 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 416
TABLE 429 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 417
TABLE 430 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 417
TABLE 431 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 418
TABLE 432 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 418
TABLE 433 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 419
TABLE 434 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 419
TABLE 435 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 420
TABLE 436 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 420
TABLE 437 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 421
TABLE 438 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 421
TABLE 439 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 422
TABLE 440 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 423
TABLE 441 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 423
TABLE 442 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 424
TABLE 443 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 424
TABLE 444 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 425
TABLE 445 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 425
TABLE 446 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 426
TABLE 447 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 426
TABLE 448 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 427
TABLE 449 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 427
TABLE 450 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 428
TABLE 451 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 428
TABLE 452 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 429
TABLE 453 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 431
TABLE 454 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 432
TABLE 455 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 432
TABLE 456 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 433
TABLE 457 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 433
TABLE 458 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 434
TABLE 459 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 434
TABLE 460 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 435
TABLE 461 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 435
TABLE 462 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 436
TABLE 463 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 436
TABLE 464 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 437
TABLE 465 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 437
TABLE 466 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 438
TABLE 467 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 438
TABLE 468 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 439
TABLE 469 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 440
TABLE 470 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 440
TABLE 471 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 441
TABLE 472 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 441
TABLE 473 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 442
TABLE 474 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 442
TABLE 475 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 443
TABLE 476 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 443
TABLE 477 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 444
TABLE 478 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 444
TABLE 479 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 445
TABLE 480 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 445
TABLE 481 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 446
TABLE 482 CHINA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 447
TABLE 483 CHINA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 447
TABLE 484 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 448
TABLE 485 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 448
TABLE 486 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 449
TABLE 487 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 449
TABLE 488 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 450
TABLE 489 CHINA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 450
TABLE 490 CHINA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 451
TABLE 491 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 451
TABLE 492 CHINA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 452
TABLE 493 CHINA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 452
TABLE 494 CHINA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 453
TABLE 495 CHINA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 453
TABLE 496 CHINA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 454
TABLE 497 CHINA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 455
TABLE 498 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 455
TABLE 499 CHINA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 456
TABLE 500 CHINA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 456
TABLE 501 CHINA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 457
TABLE 502 CHINA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 457
TABLE 503 CHINA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 458
TABLE 504 CHINA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 458
TABLE 505 CHINA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 459
TABLE 506 CHINA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 459
TABLE 507 CHINA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 460
TABLE 508 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 460
TABLE 509 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 461
TABLE 510 JAPAN: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 462
TABLE 511 JAPAN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 462
TABLE 512 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 463
TABLE 513 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 463
TABLE 514 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 464
TABLE 515 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 464
TABLE 516 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 465
TABLE 517 JAPAN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 465
TABLE 518 JAPAN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 466
TABLE 519 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 466
TABLE 520 JAPAN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 467
TABLE 521 JAPAN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 467
TABLE 522 JAPAN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 468
TABLE 523 JAPAN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 468
TABLE 524 JAPAN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 469
TABLE 525 JAPAN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 470
TABLE 526 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 470
TABLE 527 JAPAN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 471
TABLE 528 JAPAN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 471
TABLE 529 JAPAN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 472
TABLE 530 JAPAN: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 472
TABLE 531 JAPAN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 473
TABLE 532 JAPAN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 473
TABLE 533 JAPAN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 474
TABLE 534 JAPAN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 474
TABLE 535 JAPAN: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 475
TABLE 536 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 475
TABLE 537 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 476
TABLE 538 INDIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 477
TABLE 539 INDIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 477
TABLE 540 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 478
TABLE 541 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 478
TABLE 542 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 479
TABLE 543 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 479
TABLE 544 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 480
TABLE 545 INDIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 480
TABLE 546 INDIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 481
TABLE 547 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 481
TABLE 548 INDIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 482
TABLE 549 INDIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 482
TABLE 550 INDIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 483
TABLE 551 INDIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 483
TABLE 552 INDIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 484
TABLE 553 INDIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 485
TABLE 554 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 485
TABLE 555 INDIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 486
TABLE 556 INDIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 486
TABLE 557 INDIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 487
TABLE 558 INDIA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 487
TABLE 559 INDIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 488
TABLE 560 INDIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 488
TABLE 561 INDIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 489
TABLE 562 INDIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 489
TABLE 563 INDIA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 490
TABLE 564 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 490
TABLE 565 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 491
TABLE 566 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 492
TABLE 567 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 492
TABLE 568 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 493
TABLE 569 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 493
TABLE 570 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 494
TABLE 571 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 494
TABLE 572 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 495
TABLE 573 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 495
TABLE 574 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 496
TABLE 575 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 496
TABLE 576 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 497
TABLE 577 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 497
TABLE 578 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 498
TABLE 579 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 498
TABLE 580 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 499
TABLE 581 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 500
TABLE 582 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 500
TABLE 583 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 501
TABLE 584 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 501
TABLE 585 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 502
TABLE 586 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 502
TABLE 587 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 503
TABLE 588 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 503
TABLE 589 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 504
TABLE 590 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 504
TABLE 591 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 505
TABLE 592 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 505
TABLE 593 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 506
TABLE 594 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 507
TABLE 595 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 508
TABLE 596 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 508
TABLE 597 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 509
TABLE 598 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 509
TABLE 599 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 510
TABLE 600 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 510
TABLE 601 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 511
TABLE 602 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 511
TABLE 603 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 512
TABLE 604 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 512
TABLE 605 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 513
TABLE 606 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 513
TABLE 607 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 514
TABLE 608 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 514
TABLE 609 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 515
TABLE 610 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 516
TABLE 611 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 516
TABLE 612 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 517
TABLE 613 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 518
TABLE 614 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 518
TABLE 615 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 519
TABLE 616 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 519
TABLE 617 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 520
TABLE 618 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 520
TABLE 619 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 521
TABLE 620 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 521
TABLE 621 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 522
TABLE 622 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 522
TABLE 623 BRAZIL: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 523
TABLE 624 BRAZIL: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 524
TABLE 625 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 524
TABLE 626 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 525
TABLE 627 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 525
TABLE 628 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 526
TABLE 629 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 526
TABLE 630 BRAZIL: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 527
TABLE 631 BRAZIL: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 527
TABLE 632 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 528
TABLE 633 BRAZIL: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 528
TABLE 634 BRAZIL: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 529
TABLE 635 BRAZIL: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 529
TABLE 636 BRAZIL: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 530
TABLE 637 BRAZIL: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 530
TABLE 638 BRAZIL: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 531
TABLE 639 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 531
TABLE 640 BRAZIL: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 532
TABLE 641 BRAZIL: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 532
TABLE 642 BRAZIL: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 533
TABLE 643 BRAZIL: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 533
TABLE 644 BRAZIL: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 534
TABLE 645 BRAZIL: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 534
TABLE 646 BRAZIL: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 535
TABLE 647 BRAZIL: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 535
TABLE 648 BRAZIL: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 536
TABLE 649 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 536
TABLE 650 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 537
TABLE 651 MEXICO: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 538
TABLE 652 MEXICO: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 538
TABLE 653 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 539
TABLE 654 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 539
TABLE 655 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 540
TABLE 656 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 540
TABLE 657 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 541
TABLE 658 MEXICO: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 541
TABLE 659 MEXICO: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 542
TABLE 660 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 542
TABLE 661 MEXICO: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 543
TABLE 662 MEXICO: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 543
TABLE 663 MEXICO: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 544
TABLE 664 MEXICO: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 544
TABLE 665 MEXICO: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 545
TABLE 666 MEXICO: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 546
TABLE 667 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 546
TABLE 668 MEXICO: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 547
TABLE 669 MEXICO: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 547
TABLE 670 MEXICO: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 548
TABLE 671 MEXICO: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 548
TABLE 672 MEXICO: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 549
TABLE 673 MEXICO: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 549
TABLE 674 MEXICO: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 550
TABLE 675 MEXICO: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 550
TABLE 676 MEXICO: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 551
TABLE 677 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 551
TABLE 678 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE 2022–2030 (USD MILLION) 552
TABLE 679 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 553
TABLE 680 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 553
TABLE 681 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 554
TABLE 682 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 554
TABLE 683 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 555
TABLE 684 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 555
TABLE 685 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 556
TABLE 686 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 556
TABLE 687 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 557
TABLE 688 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 557
TABLE 689 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 558
TABLE 690 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 558
TABLE 691 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 559
TABLE 692 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 559
TABLE 693 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 560
TABLE 694 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 561
TABLE 695 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 561
TABLE 696 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 562
TABLE 697 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 562
TABLE 698 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 563
TABLE 699 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 563
TABLE 700 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 564
TABLE 701 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 564
TABLE 702 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 565
TABLE 703 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 565
TABLE 704 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 566
TABLE 705 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 566
TABLE 706 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 567
TABLE 707 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY REGION, 2022–2030 (USD MILLION) 569
TABLE 708 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 569
TABLE 709 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 570
TABLE 710 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 570
TABLE 711 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 571
TABLE 712 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 571
TABLE 713 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 572
TABLE 714 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 572
TABLE 715 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 573
TABLE 716 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 573
TABLE 717 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 574
TABLE 718 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 574
TABLE 719 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 575
TABLE 720 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 575
TABLE 721 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 576
TABLE 722 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 576
TABLE 723 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 577
TABLE 724 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 577
TABLE 725 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 578
TABLE 726 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 578
TABLE 727 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 579
TABLE 728 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 579
TABLE 729 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 580
TABLE 730 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 580
TABLE 731 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 581
TABLE 732 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 581
TABLE 733 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 582
TABLE 734 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 582
TABLE 735 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 583
TABLE 736 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 584
TABLE 737 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 584
TABLE 738 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 585
TABLE 739 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 585
TABLE 740 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 586
TABLE 741 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 586
TABLE 742 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 587
TABLE 743 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 587
TABLE 744 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 588
TABLE 745 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 588
TABLE 746 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 589
TABLE 747 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 589
TABLE 748 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 590
TABLE 749 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 590
TABLE 750 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 591
TABLE 751 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 592
TABLE 752 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 592
TABLE 753 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 593
TABLE 754 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 593
TABLE 755 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 594
TABLE 756 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 594
TABLE 757 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 595
TABLE 758 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 595
TABLE 759 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 596
TABLE 760 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 596
TABLE 761 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 597
TABLE 762 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 597
TABLE 763 GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 598
TABLE 764 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION) 599
TABLE 765 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 599
TABLE 766 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION) 600
TABLE 767 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 600
TABLE 768 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 601
TABLE 769 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 601
TABLE 770 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 602
TABLE 771 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION) 602
TABLE 772 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 603
TABLE 773 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 603
TABLE 774 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION) 604
TABLE 775 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION) 604
TABLE 776 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 605
TABLE 777 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 605
TABLE 778 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 606
TABLE 779 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION) 607
TABLE 780 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 607
TABLE 781 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION) 608
TABLE 782 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 609
TABLE 783 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 609
TABLE 784 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION) 610
TABLE 785 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 610
TABLE 786 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 611
TABLE 787 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 611
TABLE 788 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION) 612
TABLE 789 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION) 612
TABLE 790 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 613
TABLE 791 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 613
TABLE 792 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, JANUARY 2021–NOVEMBER 2024 614
TABLE 793 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE ANALYSIS, 2023 619
TABLE 794 AI IN HEALTHCARE MARKET: REGION FOOTPRINT 624
TABLE 795 AI IN HEALTHCARE MARKET: APPLICATION FOOTPRINT 625
TABLE 796 AI IN HEALTHCARE MARKET: TOOL FOOTPRINT 626
TABLE 797 AI IN HEALTHCARE MARKET: FUNCTION FOOTPRINT 627
TABLE 798 AI IN HEALTHCARE MARKET: OFFERING FOOTPRINT 628
TABLE 799 AI IN HEALTHCARE MARKET: DEPLOYMENT FOOTPRINT 629
TABLE 800 AI IN HEALTHCARE MARKET: END-USER FOOTPRINT 630
TABLE 801 AI IN HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 633
TABLE 802 AI IN HEALTHCARE MARKET: REGION FOOTPRINT (STARTUPS/SMES) 633
TABLE 803 AI IN HEALTHCARE MARKET: PRODUCT LAUNCHES,
JANUARY 2021–NOVEMBER 2024 636
TABLE 804 AI IN HEALTHCARE MARKET: DEALS, JANUARY 2021–NOVEMBER 2024 637
TABLE 805 AI IN HEALTHCARE MARKET: OTHER DEVELOPMENTS,
JANUARY 2021–NOVEMBER 2024 638
TABLE 806 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 640
TABLE 807 KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED 641
TABLE 808 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES,
JANUARY 2021–NOVEMBER 2024 644
TABLE 809 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–NOVEMBER 2024 645
TABLE 810 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024 646
TABLE 811 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS,
JANUARY 2021–NOVEMBER 2024 646
TABLE 812 MICROSOFT CORPORATION: COMPANY OVERVIEW 648
TABLE 813 MICROSOFT CORPORATION: PRODUCTS & SERVICES OFFERED 650
TABLE 814 MICROSOFT CORPORATION: PRODUCT LAUNCHES,
JANUARY 2021–NOVEMBER 2024 651
TABLE 815 MICROSOFT CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 652
TABLE 816 NVIDIA CORPORATION: COMPANY OVERVIEW 656
TABLE 817 NVIDIA CORPORATION: PRODUCTS & SERVICES OFFERED 657
TABLE 818 NVIDIA CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 658
TABLE 819 NVIDIA CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 659
TABLE 820 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 661
TABLE 821 SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED 663
TABLE 822 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–NOVEMBER 2024 664
TABLE 823 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–NOVEMBER 2024 664
TABLE 824 SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 665
TABLE 825 GE HEALTHCARE: COMPANY OVERVIEW 667
TABLE 826 GE HEALTHCARE: PRODUCTS & SERVICES OFFERED 669
TABLE 827 GE HEALTHCARE: DEALS, JANUARY 2021–NOVEMBER 2024 670
TABLE 828 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 672
TABLE 829 EPIC SYSTEMS CORPORATION: PRODUCTS & SERVICES OFFERED 672
TABLE 830 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 673
TABLE 831 ORACLE: COMPANY OVERVIEW 674
TABLE 832 ORACLE: PRODUCTS & SERVICES OFFERED 676
TABLE 833 ORACLE: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024 677
TABLE 834 ORACLE: DEALS, JANUARY 2021–MARCH 2024 677
TABLE 835 VERADIGM LLC: COMPANY OVERVIEW 679
TABLE 836 VERADIGM LLC: PRODUCTS & SERVICES OFFERED 680
TABLE 837 VERADIGM LLC: DEALS, JANUARY 2021–MARCH 2024 681
TABLE 838 AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW 682
TABLE 839 AMAZON WEB SERVICES, INC.: PRODUCTS & SERVICES OFFERED 683
TABLE 840 AMAZON WEB SERVICES, INC.: PRODUCT LAUNCHES,
JANUARY 2021–MARCH 2024 684
TABLE 841 AMAZON WEB SERVICES, INC.: DEALS, JANUARY 2021–MARCH 2024 685
TABLE 842 IBM: COMPANY OVERVIEW 686
TABLE 843 MERATIVE: PRODUCTS & SERVICES OFFERED 687
TABLE 844 MERATIVE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 688
TABLE 845 MERATIVE: DEALS, JANUARY 2021–NOVEMBER 2024 689
TABLE 846 MEDTRONIC: COMPANY OVERVIEW 690
TABLE 847 MEDTRONIC: PRODUCTS & SERVICES OFFERED 691
TABLE 848 MEDTRONIC: DEALS, JANUARY 2021–NOVEMBER 2024 692
TABLE 849 GOOGLE: COMPANY OVERVIEW 693
TABLE 850 GOOGLE: PRODUCTS & SERVICES OFFERED 694
TABLE 851 GOOGLE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 695
TABLE 852 GOOGLE: DEALS, JANUARY 2021–NOVEMBER 2024 696
TABLE 853 GOOGLE: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 697
TABLE 854 SOPHIA GENETICS: COMPANY OVERVIEW 698
TABLE 855 SOPHIA GENETICS: PRODUCTS & SERVICES OFFERED 699
TABLE 856 SOPHIA GENETICS: DEALS, JANUARY 2021–NOVEMBER 2024 699
TABLE 857 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 700
TABLE 858 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS & SERVICES OFFERED 701
TABLE 859 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2021–NOVEMBER 2024 702
TABLE 860 TEMPUS: COMPANY OVERVIEW 703
TABLE 861 TEMPUS: PRODUCTS & SERVICES OFFERED 704
TABLE 862 TEMPUS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–NOVEMBER 2024 705
TABLE 863 TEMPUS: DEALS, JANUARY 2021–NOVEMBER 2024 705
TABLE 864 CONCERTAI: COMPANY OVERVIEW 706
TABLE 865 CONCERTAI: PRODUCTS & SERVICES OFFERED 706
TABLE 866 CONCERTAI: PRODUCT LAUNCHES & UPGRADES,
JANUARY 2021–NOVEMBER 2024 707
TABLE 867 CONCERTAI: DEALS, JANUARY 2021–MARCH 2024 708
TABLE 868 3M: COMPANY OVERVIEW 709
TABLE 869 3M: PRODUCTS & SERVICES OFFERED 710
TABLE 870 3M: DEALS, JANUARY 2021–NOVEMBER 2024 710
TABLE 871 COGNIZANT: COMPANY OVERVIEW 711
TABLE 872 COGNIZANT: PRODUCTS & SERVICES OFFERED 712
TABLE 873 COGNIZANT: PRODUCT LAUNCHES & UPGRADES,
JANUARY 2021–NOVEMBER 2024 713
TABLE 874 COGNIZANT: DEALS, JANUARY 2021–NOVEMBER 2024 714
TABLE 875 VIZ.AI, INC.: COMPANY OVERVIEW 715
TABLE 876 VIZ.AI, INC.: PRODUCTS & SERVICES OFFERED 715
TABLE 877 VIZ.AI, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024 716
TABLE 878 VIZ.AI, INC.: DEALS, JANUARY 2021–NOVEMBER 2024 716
TABLE 879 VIZ.AI, INC.: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024 718
TABLE 880 RIVERAIN TECHNOLOGIES: COMPANY OVERVIEW 719
TABLE 881 RIVERAIN TECHNOLOGIES: PRODUCTS & SERVICES OFFERED 719
TABLE 882 RIVERAIN TECHNOLOGIES: DEALS, JANUARY 2021–NOVEMBER 2024 720
LIST OF FIGURES
FIGURE 1 AI IN HEALTHCARE MARKET SEGMENTATION & REGIONAL SCOPE 58
FIGURE 2 RESEARCH DESIGN 65
FIGURE 3 PRIMARY SOURCES 68
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 69
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 70
FIGURE 6 BOTTOM-UP APPROACH: END-USER SPENDING ON AI IN HEALTHCARE 71
FIGURE 7 AI IN HEALTHCARE MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030) 73
FIGURE 8 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 74
FIGURE 9 TOP-DOWN APPROACH 74
FIGURE 10 DATA TRIANGULATION METHODOLOGY 76
FIGURE 11 AI IN HEALTHCARE MARKET, BY OFFERING, 2024 VS. 2030 (USD MILLION) 79
FIGURE 12 AI IN HEALTHCARE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION) 80
FIGURE 13 AI IN HEALTHCARE MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION) 81
FIGURE 14 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024 VS. 2030 (USD MILLION) 81
FIGURE 15 AI IN HEALTHCARE MARKET, BY TOOL, 2024 VS. 2030 (USD MILLION) 82
FIGURE 16 AI IN HEALTHCARE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 83
FIGURE 17 AI IN HEALTHCARE MARKET: REGIONS COVERED 84
FIGURE 18 RISING NEED FOR EARLY DISEASE DETECTION TO DRIVE MARKET 85
FIGURE 19 JAPAN TO DOMINATE MARKET IN ASIA PACIFIC IN 2024 86
FIGURE 20 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 87
FIGURE 21 NORTH AMERICA TO DOMINATE AI IN HEALTHCARE MARKET DURING FORECAST PERIOD 87
FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 88
FIGURE 23 AI IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 89
FIGURE 24 DATA BREACHES IN HEALTHCARE SECTOR, 2019–2023 99
FIGURE 25 CHALLENGES ASSOCIATED WITH HEALTHCARE DATA INTEROPERABILITY 100
FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 101
FIGURE 27 AI IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS 107
FIGURE 28 AI IN HEALTHCARE MARKET: ECOSYSTEM MAPPING 109
FIGURE 29 AI IN HEALTHCARE MARKET: PATENTS GRANTED, 2013–2023 115
FIGURE 30 AI IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 128
FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 130
FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS 131
FIGURE 33 AI IN HEALTHCARE MARKET: INVESTMENT & FUNDING SCENARIO, 2024 135
FIGURE 34 GEN AI USE CASES IN HEALTHCARE 137
FIGURE 35 NORTH AMERICA: AI IN HEALTHCARE MARKET SNAPSHOT 276
FIGURE 36 EUROPE: AI IN HEALTHCARE MARKET SNAPSHOT 323
FIGURE 37 ASIA PACIFIC: AI IN HEALTHCARE MARKET SNAPSHOT 430
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2019–2023 618
FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2023 619
FIGURE 40 RANKING OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2023 621
FIGURE 41 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 622
FIGURE 42 AI IN HEALTHCARE MARKET: COMPANY FOOTPRINT 623
FIGURE 43 AI IN HEALTHCARE MARKET:
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 632
FIGURE 44 EV/EBITDA OF KEY VENDORS 634
FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 634
FIGURE 46 AI IN HEALTHCARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 635
FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023) 641
FIGURE 48 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2023) 649
FIGURE 49 NVIDIA CORPORATION: COMPANY SNAPSHOT (2023) 657
FIGURE 50 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 662
FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 668
FIGURE 52 ORACLE: COMPANY SNAPSHOT (2023) 675
FIGURE 53 VERADIGM LLC: COMPANY SNAPSHOT (2021) 680
FIGURE 54 AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT (2023) 683
FIGURE 55 IBM: COMPANY SNAPSHOT (2023) 687
FIGURE 56 MEDTRONIC: COMPANY SNAPSHOT (2023) 691
FIGURE 57 GOOGLE: COMPANY SNAPSHOT (2023) 694
FIGURE 58 SOPHIA GENETICS: COMPANY SNAPSHOT (2023) 698
FIGURE 59 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023) 701
FIGURE 60 3M: COMPANY SNAPSHOT (2023) 709
FIGURE 61 COGNIZANT: COMPANY SNAPSHOT (2023) 712